Shares of PURE Bioscience (OTCMKTS:PURE – Get Free Report) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.08 and traded as high as $0.10. PURE Bioscience shares last traded at $0.09, with a volume of 53,672 shares traded.
PURE Bioscience Price Performance
The company has a market cap of $10.01 million, a PE ratio of -2.24 and a beta of 0.41. The company’s 50 day simple moving average is $0.09 and its two-hundred day simple moving average is $0.08.
About PURE Bioscience
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Featured Articles
- Five stocks we like better than PURE Bioscience
- Market Cap Calculator: How to Calculate Market Cap
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- How Technical Indicators Can Help You Find Oversold Stocks
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- Quiet Period Expirations Explained
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
